What if there was an entirely new drug modality to enable the body to produce its own healing proteins in vivo?

learn more

We are delivering the next wave of innovation to treat serious illness.

here's how

Moderna and AstraZeneca have a strategic option agreement to develop up to forty messenger RNA Therapeutics™ for the treatment of serious cardiometabolic diseases and cancer.

learn more

We’ve assembled a team of scientists and drug hunters, executives and visionaries. Our experience is matched only by our passion.

get to know us

We are enabling an entirely new drug modality across a vast range of diseases—many of which cannot be treated with existing drugs.

see our potential

1
2
3
4
5

How messenger RNA Therapeutics Work
watch our video

What's New

May 22, 2013

John Reynders will join Moderna in early July as its first Chief Information Officer. | Read more

April 30, 2013

Moderna welcomes Henri A. Termeer, former CEO of Genzyme, to its board of directors. | Read more

March 21, 2013

AstraZeneca and Moderna Therapeutics announce exclusive strategic alliance to develop messenger RNA therapeutics™ in cardiometabolic diseases and cancer. | Read more